DuckDB: An Embedded In-Memory Database

DuckDB: An Embedded In-Memory Database

Introduction Traditional relational databases, such as MySQL and PostgreSQL, often face performance bottlenecks when handling large-scale data. Data warehouses require complex deployment and maintenance. A “newcomer” in the database field—DuckDB—is changing the way we analyze data with its unique charm. What is DuckDB? In simple terms, DuckDB is anembedded, in-process, OLAP database. Embedded: This means … Read more

Application of SIMD Technology in MPP Databases

Application of SIMD Technology in MPP Databases

1. Background SIMD stands for (Single Instruction Multiple Data), representing the ability to operate on a batch of data with a single instruction, allowing parallel operations on multiple sets of data with a set of instructions. This technology was first applied in video acceleration decoding, where Intel’s Pentium series introduced MMX (Multi-Media Extensions) technology to … Read more

Innovative Architecture of GoldenDB Distributed Database Integrated with All-Flash SAN Storage for OLTP/OLAP Mixed Load in a Bank

Innovative Architecture of GoldenDB Distributed Database Integrated with All-Flash SAN Storage for OLTP/OLAP Mixed Load in a Bank

【Abstract】 The banking industry widely uses databases, facing common challenges such as a variety of databases in non-core applications, complex SQL queries, and large volumes of historical data. These issues pose significant challenges for replacing domestic databases in non-core important systems. This article starts from the characteristics and transformation difficulties of these business systems, analyzes … Read more

Evaluation of a Novel Signature for PARP Inhibitor Sensitivity Prediction

Evaluation of a Novel Signature for PARP Inhibitor Sensitivity Prediction

Evaluation of a novel signature for PARP inhibitor sensitivity prediction using real-world data. Evaluation of a novel PARP inhibitor sensitivity biomarker using real-world data. First Author: Emily Vucic, Zephyr AI Background Tumors with homologous recombination repair deficiencies (HRD+) are susceptible to PARP inhibitors (PARPi) which exploit a synthetic lethality by targeting an essential base excision … Read more